Top Key Companies for Glucocorticoids Market: Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla, Abbott Laboratories, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd, Shandong Xinhua Pharmaceutical Company Limited, Yangzi River Pharmaceutical Group.
Global Glucocorticoids Market Size was estimated at USD 16060 million in 2022 and is projected to reach USD 24088.22 million by 2028, exhibiting a CAGR of 6.99% during the forecast period.
Global Glucocorticoids Market Overview And Scope:
The Global Glucocorticoids Market Report 2026 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Glucocorticoids utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2026 and 2035. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Glucocorticoids Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glucocorticoids portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Glucocorticoids market.
Global Glucocorticoids Market Segmentation
By Type, Glucocorticoids market has been segmented into:
Cortisone
Prednisone
Prednisolone
Methylprednisolone
Dexamethasone
Betamethasone
Hydrocortisone
Others
By Application, Glucocorticoids market has been segmented into:
Anti-inflammatory
Immunosuppressive
Vasoconstrictive
Regional Analysis of Glucocorticoids Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Glucocorticoids Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Glucocorticoids market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Glucocorticoids market.
Top Key Companies Covered in Glucocorticoids market are:
Pfizer
Novartis
Aspen
Euroapi
Sanofi
Avik Pharmaceutical Limited
Symbiotec
Cipla
Abbott Laboratories
Tianjin Tianyao Pharmaceuticals Co.
Ltd.
Zhejiang Xianju Pharmaceutical Co.
Ltd
Shandong Xinhua Pharmaceutical Company Limited
Yangzi River Pharmaceutical Group
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Glucocorticoids Market by Type
5.1 Glucocorticoids Market Overview Snapshot and Growth Engine
5.2 Glucocorticoids Market Overview
5.3 Cortisone
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2026-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Cortisone: Geographic Segmentation
5.4 Prednisone
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2026-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Prednisone: Geographic Segmentation
5.5 Prednisolone
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2026-2035F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Prednisolone: Geographic Segmentation
5.6 Methylprednisolone
5.6.1 Introduction and Market Overview
5.6.2 Historic and Forecasted Market Size (2026-2035F)
5.6.3 Key Market Trends, Growth Factors and Opportunities
5.6.4 Methylprednisolone: Geographic Segmentation
5.7 Dexamethasone
5.7.1 Introduction and Market Overview
5.7.2 Historic and Forecasted Market Size (2026-2035F)
5.7.3 Key Market Trends, Growth Factors and Opportunities
5.7.4 Dexamethasone: Geographic Segmentation
5.8 Betamethasone
5.8.1 Introduction and Market Overview
5.8.2 Historic and Forecasted Market Size (2026-2035F)
5.8.3 Key Market Trends, Growth Factors and Opportunities
5.8.4 Betamethasone: Geographic Segmentation
5.9 Hydrocortisone
5.9.1 Introduction and Market Overview
5.9.2 Historic and Forecasted Market Size (2026-2035F)
5.9.3 Key Market Trends, Growth Factors and Opportunities
5.9.4 Hydrocortisone: Geographic Segmentation
5.10 Others
5.10.1 Introduction and Market Overview
5.10.2 Historic and Forecasted Market Size (2026-2035F)
5.10.3 Key Market Trends, Growth Factors and Opportunities
5.10.4 Others: Geographic Segmentation
Chapter 6: Glucocorticoids Market by Application
6.1 Glucocorticoids Market Overview Snapshot and Growth Engine
6.2 Glucocorticoids Market Overview
6.3 Anti-inflammatory
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2026-2035F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Anti-inflammatory: Geographic Segmentation
6.4 Immunosuppressive
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2026-2035F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Immunosuppressive: Geographic Segmentation
6.5 Vasoconstrictive
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2026-2035F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Vasoconstrictive: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Glucocorticoids Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Glucocorticoids Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Glucocorticoids Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 PFIZER
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 NOVARTIS
7.4 ASPEN
7.5 EUROAPI
7.6 SANOFI
7.7 AVIK PHARMACEUTICAL LIMITED
7.8 SYMBIOTEC
7.9 CIPLA
7.10 ABBOTT LABORATORIES
7.11 TIANJIN TIANYAO PHARMACEUTICALS CO.
7.12 LTD.
7.13 ZHEJIANG XIANJU PHARMACEUTICAL CO.
7.14 LTD
7.15 SHANDONG XINHUA PHARMACEUTICAL COMPANY LIMITED
7.16 YANGZI RIVER PHARMACEUTICAL GROUP
Chapter 8: Global Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Cortisone
8.2.2 Prednisone
8.2.3 Prednisolone
8.2.4 Methylprednisolone
8.2.5 Dexamethasone
8.2.6 Betamethasone
8.2.7 Hydrocortisone
8.2.8 Others
8.3 Historic and Forecasted Market Size By Application
8.3.1 Anti-inflammatory
8.3.2 Immunosuppressive
8.3.3 Vasoconstrictive
Chapter 9: North America Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Cortisone
9.4.2 Prednisone
9.4.3 Prednisolone
9.4.4 Methylprednisolone
9.4.5 Dexamethasone
9.4.6 Betamethasone
9.4.7 Hydrocortisone
9.4.8 Others
9.5 Historic and Forecasted Market Size By Application
9.5.1 Anti-inflammatory
9.5.2 Immunosuppressive
9.5.3 Vasoconstrictive
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Cortisone
10.4.2 Prednisone
10.4.3 Prednisolone
10.4.4 Methylprednisolone
10.4.5 Dexamethasone
10.4.6 Betamethasone
10.4.7 Hydrocortisone
10.4.8 Others
10.5 Historic and Forecasted Market Size By Application
10.5.1 Anti-inflammatory
10.5.2 Immunosuppressive
10.5.3 Vasoconstrictive
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Cortisone
11.4.2 Prednisone
11.4.3 Prednisolone
11.4.4 Methylprednisolone
11.4.5 Dexamethasone
11.4.6 Betamethasone
11.4.7 Hydrocortisone
11.4.8 Others
11.5 Historic and Forecasted Market Size By Application
11.5.1 Anti-inflammatory
11.5.2 Immunosuppressive
11.5.3 Vasoconstrictive
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Cortisone
12.4.2 Prednisone
12.4.3 Prednisolone
12.4.4 Methylprednisolone
12.4.5 Dexamethasone
12.4.6 Betamethasone
12.4.7 Hydrocortisone
12.4.8 Others
12.5 Historic and Forecasted Market Size By Application
12.5.1 Anti-inflammatory
12.5.2 Immunosuppressive
12.5.3 Vasoconstrictive
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Cortisone
13.4.2 Prednisone
13.4.3 Prednisolone
13.4.4 Methylprednisolone
13.4.5 Dexamethasone
13.4.6 Betamethasone
13.4.7 Hydrocortisone
13.4.8 Others
13.5 Historic and Forecasted Market Size By Application
13.5.1 Anti-inflammatory
13.5.2 Immunosuppressive
13.5.3 Vasoconstrictive
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Glucocorticoids Market Analysis, Insights and Forecast, 2026-2035
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Cortisone
14.4.2 Prednisone
14.4.3 Prednisolone
14.4.4 Methylprednisolone
14.4.5 Dexamethasone
14.4.6 Betamethasone
14.4.7 Hydrocortisone
14.4.8 Others
14.5 Historic and Forecasted Market Size By Application
14.5.1 Anti-inflammatory
14.5.2 Immunosuppressive
14.5.3 Vasoconstrictive
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Glucocorticoids Scope:
|
Report Data
|
Glucocorticoids Market
|
|
Glucocorticoids Market Size in 2025
|
USD XX million
|
|
Glucocorticoids CAGR 2025 - 2032
|
XX%
|
|
Glucocorticoids Base Year
|
2024
|
|
Glucocorticoids Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Pfizer, Novartis, Aspen, Euroapi, Sanofi, Avik Pharmaceutical Limited, Symbiotec, Cipla, Abbott Laboratories, Tianjin Tianyao Pharmaceuticals Co., Ltd., Zhejiang Xianju Pharmaceutical Co.,Ltd, Shandong Xinhua Pharmaceutical Company Limited, Yangzi River Pharmaceutical Group.
|
|
Key Segments
|
By Type
Cortisone
Prednisone
Prednisolone
Methylprednisolone
Dexamethasone
Betamethasone
Hydrocortisone
Others
By Applications
Anti-inflammatory
Immunosuppressive
Vasoconstrictive
|
